// App-Quantinova.ai

PO0005 : Secondary prevention of cardiogenic arterial thromboembolism in a patient with atrial fibrillation and thrombus in left ventricule

Researchers

Presenter

  • T. Saralidze

Principal Investigators

  • T. Svanidze

  • I. Mamatsashvili

  • M. Noniashvili

Medical Centers

  • Tbilisi State Medical University, Tbilisi, Shida Kartli, Georgia

Locations

  • Georgia

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Nephrology

  • Endocrine/metabolic Diseases (ME)

  • Central Nervous System (CNS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Pulmonary arterial hypertension

  • Left ventricular hypertrophy

  • Myocardial infarction

  • Chronic kidney disease

  • Arrhythmia

  • Congestive heart failure

  • Venous thrombosis

  • Encephalopathy

  • Renal disease

  • Hypertension

  • Albuminuria

  • Anemia

Biomarkers

  • Body mass index

Drug/Treatment

  • rivaroxaban

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved